CN Patent

CN109666019B — 一种氘代的氮唑醇类化合物及其制备方法和用途

Assigned to Shanghai entefang Biomedical Technology Co.,Ltd. · Expires 2021-04-06 · 5y expired

What this patent protects

本发明公开了如式(I)所示的氘代氮唑醇类化合物及其可药用盐和前药的制备方法和用途。本发明所述的氘代氮唑醇类化合物具有较好的抗真菌活性同时具有较好的代谢稳定性，可用于制备抗真菌药物。

USPTO Abstract

本发明公开了如式(I)所示的氘代氮唑醇类化合物及其可药用盐和前药的制备方法和用途。本发明所述的氘代氮唑醇类化合物具有较好的抗真菌活性同时具有较好的代谢稳定性，可用于制备抗真菌药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN109666019B
Jurisdiction
CN
Classification
—
Expires
2021-04-06
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai entefang Biomedical Technology Co.,Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.